gebhart/patrepeval huggingface dataset:
VLSI implementation of MIMO detection using the sphere decoding algorithm (2005)

Multiple-input multiple-output (MIMO) techniques are a key enabling technology for high-rate wireless communications. This paper discusses two ASIC implementations of MIMO sphere decoders. The first ASIC attains maximum-likelihood performance with an average throughput of 73 Mb/s at a signal-to-noise ratio (SNR) of 20 dB; the second ASIC shows only a negligible bit-error-rate degradation and achieves a throughput of 170 Mb/s at the same SNR. The three key contributing factors to high throughput and low complexity are: depth-first tree traversal with radius reduction, implemented in a one-node-per-cycle architecture, the use of the /spl lscr//sup /spl infin//-instead of /spl lscr//sup 2/-norm, and, finally, the efficient implementation of the enumeration approach recently proposed in . The resulting ASICs currently rank among the fastest reported MIMO detector implementations.
Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS (2002)

Transplantation of myelin-forming glial cells may provide a means of achieving remyelination in situations in which endogenous remyelination fails. For this type of cell therapy to be successful, cells will have to migrate long distances in normal tissue and within areas of demyelination. In this study, 40 Gy of X-irradiation was used to deplete tissue of endogenous oligodendrocyte progenitors (OPCs). By transplanting neonatal OPCs into OPC-depleted tissue, we were able to examine the speed with which neonatal OPCs repopulate OPC-depleted tissue. Using antibodies to NG-2 proteoglycan and in situ hybridisation to detect platelet-derived growth factor alpha-receptor Ralpha (PDGFRalpha) mRNA to visualise OPCs, we were able to show that neonatal OPCs repopulate OPC-depleted normal tissue 3-5 times more rapidly than endogenous OPCs. Transplanted neonatal OPCs restore OPC densities to near-normal values and when demyelinating lesions were made in tissue into which transplanted OPCs had been incorporated 1 month previously, we were able to show that the transplanted cells retain a robust ability to remyelinate axons after their integration into host tissue. In order to model the situation that would exist in a large OPC-depleted area of demyelination such as may occur in humans; we depleted tissue of its endogenous OPC population and placed focal demyelinating lesions at a distance (< or =1 cm) from a source of neonatal OPCs. In this situation, cells would have to repopulate depleted tissue in order to reach the area of demyelination. As the repopulation process would take time, this model allowed us to examine the consequences of delaying the interaction between OPCs and demyelinated axons on remyelination. Using this approach, we have obtained data that suggest that delaying the time of the interaction between OPCs and demyelinated axons restricts the expression of the remyelinating potential of transplanted OPCs.
Anti-Idiotypic Antibody as the Surrogate Antigen for Cloning scFv and its Fusion Proteins (2002)

Single-chain variable fragment (ScFv) is a versatile building block for novel targeting constructs. However, a reliable screening and binding assay is often the limiting step for antigens that are difficult to clone or purify. Anti-idiotypic antibodies may be useful as surrogate antigens for cloning scFv and their fusion proteins. 8H9 is a murine IgG(1) monoclonal antibody (MAb) specific for a novel antigen expressed on the cell surface of a wide spectrum of human solid tumors, but not in normal tissues. Rat anti-8H9-idiotypic hybridomas (clones 2E9, 1E12, and 1F11) were produced by somatic cell fusion between rat lymphocytes and mouse SP2/0 myeloma. In direct binding assays enzyme-linked immunosorbant assay--(ELISA)--they were specific for the 8H9 idiotope. Using 2E9 as the surrogate antigen, 8H9-scFv was cloned from hybridoma cDNA by phage display. 8H9scFv was then fused to human-gamma1-CH2-CH3 cDNA for transduction into CHO and NSO cells. High expressors of mouse scFv-human Fc chimeric antibody were selected. The secreted homodimer reacted specifically with antigen-positive tumor cells by ELISA and by flow cytometry, inhibitable by the anti-idiotypic antibody. The reduced size resulted in a shorter half-life in vivo, while achieving comparable tumor to nontumor ratio as the native antibody 8H9. However, its in vitro activity in antibody-dependent cell-mediated cytotoxicity was modest.
Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF (1989)

Purified preparations of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF), and interleukin 3 (IL-3 or multi-CSF) alone and in combination, have been compared for their stimulatory effects on human granulocyte-macrophage colony forming cells (GM-CFC). In cultures of unseparated normal human bone marrow, the combinations of G-CSF plus IL-3 and GM-CSF plus IL-3 stimulated additive numbers of GM colonies, while GM-CSF plus G-CSF stimulated greater than additive numbers of GM colonies, compared with the sum of the colony formation obtained with each factor alone. Cultures of unseparated bone marrow, harvested from patients four to six days after administration of 5-fluorouracil (5-FU), resulted in additive GM colony formation with GM-CSF plus G-CSF, GM-CSF plus IL-3, and G-CSF plus IL-3. In order to address the possibility of secondary factor involvement in the synergistic interaction of GM-CSF and G-CSF, CD33+/CD34+ colony forming cells were separated from normal and post FU marrow by two color fluorescence activated cell sorting. In cultures of CD33+/CD34+ cells the combination of GM-CSF plus G-CSF stimulated a synergistic increase in GM colonies while GM-CSF plus IL-3 stimulated additive numbers of colonies. These results suggest that GM-CSF, G-CSF, and IL-3 stimulate distinct populations of GM-CFC. Furthermore GM-CSF and G-CSF interact synergistically and this action is a direct effect on progenitor cells not stimulated by GM-CSF or G-CSF alone.
Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus (2003)

In normal mice, stromal cell-derived factor 1 (SDF-1/CXCL12) promotes the migration, proliferation, and survival of peritoneal B1a (PerB1a) lymphocytes. Because these cells express a self-reactive repertoire and are expanded in New Zealand Black/New Zealand White (NZB/W) mice, we tested their response to SDF-1 in such mice. PerB1a lymphocytes from NZB/W mice were exceedingly sensitive to SDF-1. This greater sensitivity was due to the NZB genetic background, it was not observed for other B lymphocyte subpopulations, and it was modulated by IL-10. SDF-1 was produced constitutively in the peritoneal cavity and in the spleen. It was also produced by podocytes in the glomeruli of NZB/W mice with nephritis. The administration of antagonists of either SDF-1 or IL-10 early in life prevented the development of autoantibodies, nephritis, and death in NZB/W mice. Initiation of anti-SDF-1 mAb treatment later in life, in mice with established nephritis, inhibited autoantibody production, abolished proteinuria and Ig deposition, and reversed morphological changes in the kidneys. This treatment also counteracted B1a lymphocyte expansion and T lymphocyte activation. Therefore, PerB1a lymphocytes are abnormally sensitive to the combined action of SDF-1 and IL-10 in NZB/W mice, and SDF-1 is key in the development of autoimmunity in this murine model of lupus.
A Comparative Analysis of Evolutionary Algorithms for Function Optimisation (1996)

In this paper the Breeder Genetic Algorithms are compared against both serial and parallel Genetic Algorithms by using a wide range of optimisation functions taken from the literature. The aim is to investigate how the change of the fitness function influences their problem-- solving capabilities. The experimental findings show that the Breeder Genetic Algorithms outperform the Genetic Algorithms considered in terms of number of evaluations and robustness. I. Introduction A wide variety of heuristic techniques has been proposed to solve different kinds of optimisation problems. Among these, the Genetic Algorithms (GAs) [1; 2] and their parallel versions [3] should be mentioned. They have proved to be able to efficiently solve difficult optimisation problems. Recently a novel technique, the Breeder Genetic Algorithms (BGAs) [4; 5], particularly suitable to deal with continuous optimisation parameters, has been introduced. BGAs are based on the evolution model typical of GAs, however th...
Foreign Communication Systems (1989)

INTERNATIONAL HANDBOOK OF BROADCASTING SYSTEMS edited by Philip T. Rosen (Westport, CT: Greenwood Press, 1988—$55.00, ISBN 0-313-24348-4) SPLIT SIGNALS: TELEVISION AND POLITICS IN THE SOVIET UNION by Ellen Mickiewicz (New York: Oxford University Press, 1988—$22.95, ISBN 0-19-505463-6) WORLD FAMILIES WATCH TELEVISION edited by James Lull (Newbury Park, CA: Sage Publications, 1988—$35.00/$16.50, ISBN 0-8039-3254-5, paper) RESTRUCTURING OF THE TELECOMMUNICATIONS SYSTEM: REPORT OF THE GOVERNMENT COMMISSION FOR TELECOMMUNICATIONS (Heidelberg: R.v. Decker's Verlag, G. Schenck, 1988—price not given, paper, ISBN 3-7685-0688-6) THE RACE FOR VALUE-ADDED SERVICES: CHALLENGES AND OPPORTUNITIES IN THE U.S., JAPAN, AND THE U.K. by Tatsushiro Shukunami (May 1988, Paper P-88-1, 145 pp.) EC '92: THE MAKING OF A COMMON MARKET IN TELECOMMUNICATIONS by Morris H. Crawford (July 1988, Incidental Paper I-88-2, 28 pp.) BUYING HENS NOT EGGS: THE ACQUISITION OF COMMUNICATIONS AND INFORMATION TECHNOLOGY BY THE PEOPLE'S REPUBLIC OF CHINA by Robert P. Kreps (October 1988, Paper P-88-3, 119 pp.) CASE STUDIES OF STRUCTURAL ALTERATION IN THE TELECOMMUNICATIONS INDUSTRY THE UNITED KINGDOM, THE NETHERLANDS, THE FEDERAL REPUBLIC OF GERMANY, THE UNITED STATES OF AMERICA by William Garrison, Jr. (Annenberg Washington Program in Communications Policy Studies, 1455 Pennsylvania Ave. NW, Suite 200, Washington, DC 20004—price, if any, not given, paper, ISBN not provided) THE FUTURE FOR PUBLISHING ACROSS LANGUAGE FRONTIERS: REPORT OF A FORUM by J. Robert Moskin (Gutersloh, Federal Republic of Germany: Bertelsmann Foundation Publishers, 1988— price not given, paper, ISBN 3-89204-010-9) COMMUNICATIONS UPDATE: A MONTHLY ROUND-UP OF MEDIA AND COMMUNICATIONS (Communications Law Centre, Law Faculty, University of NSW, PO Box 1, Kensington, NSW 2033, Australia—$35.00 individuals/$50.00 organizations in Australian funds for 11 issues, ISSN 0815-1210)
Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein. (1998)

Lung cancer is the most frequent cause of cancer deaths in the United States. A strong correlation exists between mutations in the gene encoding the p53 tumor suppressor protein and lung malignancies. Our goal is to prepare a transgenic mouse model with disrupted p53 function in the epithelial cells of the peripheral lung. To achieve this goal, a "dominant negative" mutant form of p53 was expressed from the human surfactant protein C (SPC) promoter. The dominant negative p53 expressed from the SPC promoter will antagonize wild-type p53 functions in alveolar type II pneumocytes and some bronchiolar cells of the transgenic animals and thereby promote development of carcinoma of the lung. This animal model should prove useful to the study of lung carcinogenesis and to the identification of agents that contribute to neoplastic conversion in the lung.
Stability Of A Lateral-Shearing Heterodyne Twyman-Green Interferometer (1984)

A lateral-shearing heterodyne Twyman-Green interferometer was constructed to test lenses in transmission. The goal was to determine the repeatability of the measurement of the phase of the wavefront produced by the lens. A second interferometer was used to monitor the phase modulation used in the heterodyne scheme. The wavefront map was computed by a generalized least-squares procedure. Measured phase stabilities were better than 1 mX ( 1 m X = 10-3X, called "milliwave").
Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding (2007)

The hepatitis C virus glycoprotein E2 receptor-binding domain is encompassed by amino acids 384 to 661 (E2(661)) and contains two hypervariable sequences, HVR1 and HVR2. E2 sequence comparisons revealed a third variable region, located between residues 570 and 580, that varies widely between genotypes, designated here as igVR, the intergenotypic variable region. A secreted E2(661) glycoprotein with simultaneous deletions of the three variable sequences retained its ability to bind CD81 and conformation-dependent monoclonal antibodies (MAbs) and displayed enhanced binding to a neutralizing MAb directed to E2 immunogenic domain B. Our data provide insights into the E2 structure by suggesting that the three variable regions reside outside a conserved E2 core.
Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22.3 (2002)

Clinical otosclerosis (OMIM 166800/605727) has a prevalence of 0.2-1% among white adults, making it the single most common cause of hearing impairment in this group. It is caused by abnormal bone homeostasis of the otic capsule with the consequent development of sclerotic foci that invade the stapedio-vestibular joint (oval window) interfering with free motion of the stapes. Impaired ossicular chain mobility results in a conductive hearing loss. We identified the first locus for otosclerosis (OTSC1) on chromosome 15 in 1998 and reported a second locus (OTSC2) on chromosome 7 last year. Here we present results of a genome wide linkage study on a large Cypriot family segregating otosclerosis. Results of this study exclude linkage to OTSC1 and OTSC2 and identify a third locus, OTSC3, on chromosome 6p. The defined OTSC3 interval covers the HLA region, consistent with reported associations between HLA-A/HLA-B antigens and otosclerosis.
Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors (2004)

Abstract We subjected cells collected using an in vivo invasion assay to cDNA microarray analysis to identify the gene expression profile of invasive carcinoma cells in primary mammary tumors. Expression of genes involved in cell division, survival, and cell motility were most dramatically changed in invasive cells indicating a population that is neither dividing nor apoptotic but intensely motile. In particular, the genes coding for the minimum motility machine that regulates β-actin polymerization at the leading edge and, therefore, the motility and chemotaxis of carcinoma cells, were dramatically up-regulated. However, ZBP1, which restricts the localization of β-actin, the substrate for the minimum motility machine, was down-regulated. This pattern of expression implicated ZBP1 as a suppressor of invasion. Reexpression of ZBP1 in metastatic cells with otherwise low levels of ZBP1 reestablished normal patterns of β-actin mRNA targeting and suppressed chemotaxis and invasion in primary tumors. ZBP1 reexpression also inhibited metastasis from tumors. These experiments support the involvement in metastasis of the pathways identified in invasive cells, which are regulated by ZBP1.
Pharmacological strategies for the prevention of Alzheimer’s disease (2005)

This review examines key pharmacological strategies that have been clinically studied for the primary or secondary prevention of Alzheimer's disease. Much information (neuropsychological, genetic and imaging) is already available to characterise an individual's risk for developing Alzheimer's disease. However, regulatory pathways for obtaining a prevention indication are less well charted, and such trials tend to involve 3- to 7-year studies of 1000 - 5000 individuals, depending on baseline status. Treatments developed for prevention will also need to have superior safety. For these reasons, > 100 proprietary pharmacological products are currently being developed for an Alzheimer's disease treatment, but only a few are being studied for prevention. Randomised trial data are available for antihypertensive agents (calcium channel blockers, angiotensin-converting enzyme inhibitors), pravastatin, simvastatin, conjugated oestrogen, raloxifene, rofecoxib, CX516 (AMPA agonist) and cholinesterase inhibitors regarding efficacy for Alzheimer's disease prevention. At least four large prevention trials of conjugated oestrogen, selenium and vitamin E, Ginkgo biloba and statins are currently underway. Strategies using other agents have not yet been evaluated in Alzheimer's disease prevention clinical trials. These include anti-amyloid antibodies, active immunisation, selective secretase inhibitors and modulators, microtubule stabilisers (e.g., paclitaxel), R-flurbiprofen, xaliproden, ONO-2506, FK962 (somatostatin releaser), SGS 742 (GABA(B) antagonist), TCH 346 (apoptosis inhibitor), Alzhemedtrade mark, phophodiesterase inhibitors, rosiglitazone, leuprolide, interferons, metal-protein attenuating compounds (e.g., PBT2), CX717, rasagaline, huperzine A, antioxidants and memantine. Studies combining lifestyle modification and drug therapy have not been conducted. Full validation of surrogate markers for disease progression (such as amyloid imaging) should further facilitate drug development. Reducing the complexity of prevention trials and gaining regulatory consensus of design is a high priority for the field.
Long-term inhibition of the renin-angiotensin system in genetic hypertension (1997)

Blockade of the renin-angiotensin system appears to have an efficacy in reversing established hypertension and hypertrophy similar to that with which it prevents the development of hypertension and hypertrophy. This partial 'cure' of hypertension after withdrawal of treatment is clearly evident when treatment is initiated during the development of hypertension and appears to be similar even when treatment is initiated in established hypertension.
Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen. (1986)

Monoaryl phosphonate esters, designated as analogs of the transition state in the hydrolysis of carboxylic esters, were synthesized and used as haptens to generate specific monoclonal antibodies. Some of these antibodies react with cognate aryl carboxylic esters to release a fluorescent alcohol. The reaction appears to be stoichiometric; however, the activity is slowly regenerated under alkaline conditions or by treatment with hydroxylamine. Specificity is rigorous for esters of p-trifluoroacetamidophenylacetic acid, demonstrating a structural correspondence with the phosphonate hapten. Saturation kinetics are observed and kinetic parameters (kmax, Vmax, and Km) are reported. The haptenic phosphonate is a competitive inhibitor of the reaction (Ki, 35 nM); whereas the carboxylate product of ester hydrolysis is a less effective inhibitor (Ki, ca. 7500 nM). Chemical modification of side chain groups in the protein show a partial reduction in activity on acylation of lysine or nitration of tyrosine and a dramatic quenching upon modification of histidine. The evidence is discussed in terms of a mechanism in which amino acids of the antibody combining site participate in nucleophilic and/or general base catalysis. The properties of this system suggest that it is an example of enzymic transacylation where a deacylation step is not catalyzed. The possibility of deriving enzymic function from immunological specificity through this approach is advanced.
Catalytic biomass conversion (2013)

New and Future Developments in Catalysis is a package of books that compile the latest ideas concerning alternate and renewable energy sources and the role that catalysis plays in converting new renewable feedstock into biofuels and biochemicals. Both homogeneous and heterogeneous catalysts and catalytic processes will be discussed in a unified and comprehensive approach. There will be extensive cross-referencing within all volumes. This volume covers all the biomass sources and gives detailed and in-depth coverage of all current chemical/catalytic conversion processes of biomass into liquid hydrocarbons to be further used as a feedstock for the production of not only biofuels but a large array of chemicals. It offers an in-depth coverage of all catalytic topics of current interest and outlines the future challenges and research areas. It is a clear and visual description of all parameters and conditions enables the reader to draw conclusions for a particular case. It outlines the catalytic processes applicable to energy generation and design of green processes.
Polyoxometalates: Building Blocks for Functional Nanoscale Systems (2010)

Polyoxometalates (POMs) are a subset of metal oxides that represent a diverse range of molecular clusters with an almost unmatched range of physical properties and the ability to form dynamic structures that can range in size from the nano- to the micrometer scale. Herein we present the very latest developments from synthesis to structure and function of POMs. We discuss the possibilities of creating highly sophisticated functional hierarchical systems with multiple, interdependent, functionalities along with a critical analysis that allows the non-specialist to learn the salient features. We propose and present a "periodic table of polyoxometalate building blocks". We also highlight some of the current issues and challenges that need to be addressed to work towards the design of functional systems based upon POM building blocks and look ahead to possible emerging application areas.
Hydroxyapatite Cement: I. Basic Chemistry and Histologic Properties (1991)

Hydroxyapatite cement is a unique calcium phosphate preparation that can be shaped intraoperatively and sets in vivo to an implant composed of microporous hydroxyapatite. The histologic response to this cement was evaluated by implanting disks made of this material within the heads of nine cats. Three sets of 12 hydroxyapatite cement disks were produced containing 0%, 10%, and 20% macropores by volume, respectively. The disks were implanted subcutaneously, intramuscularly, above the periosteum of the skull, and directly onto the surface of the calvarium. Each macropore percentage was represented in each tissue plane, and animals were killed up to 9 months postoperatively. There were no toxic reactions, implants extruded, or wound infections. Histologic examination of the implant-soft-tissue interfaces revealed a transient inflammatory response without foreign body reaction. The disks were resorbed over time in direct proportion to their macropore content (surface areas) in all groups except for those disks placed directly onto the surface of the calvarium below the periosteum. In this group, numerous foci of bone formed at the skull-implant interface, with variable replacement of the deep surface of these implants by bone. Implant replacement by bone is postulated to occur through a combination of implant resorption coupled with osteoconduction. Based on these properties, hydroxyapatite cement may prove useful when applied to the reconstruction of non-stress-bearing skeletal tissue.